Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Acetylated Lysine antibody

The Mouse Monoclonal anti-Acetylated Lysine antibody is suitable to detect Acetylated Lysine. It has been validated for WB, ELISA and IHC.
Rockland
Catalog No. ABIN6655030
Supplier Product No.: 200-301-a97
$512.00
Plus shipping costs $50.00, if applicable $20.00 dry ice
100 μg
Shipping to: United States
Delivery in 1 to 3 Business Days

Quick Overview for Acetylated Lysine antibody (ABIN6655030)

Target

Acetylated Lysine

Reactivity

Please inquire

Host

  • 28
  • 17
Mouse

Clonality

  • 26
  • 18
Monoclonal

Conjugate

  • 18
  • 5
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
This Acetylated Lysine antibody is un-conjugated

Application

  • 44
  • 34
  • 33
  • 18
  • 15
  • 14
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Clone

7F8
  • Supplier Product No.

    200-301-a97

    Supplier

    Rockland

    Purpose

    Lysine Acetylated Antibody

    Cross-Reactivity (Details)

    This antibody is known to react with acetylated lysine residues from mammalian and avian sources.

    Purification

    This Protein G purified monoclonal antibody reacts with proteins containing acetylated lysine residues and does not detect non-acetylated lysine residues.

    Sterility

    Sterile filtered

    Immunogen

    This Protein G purified monoclonal antibody was prepared using conventional hybridoma technology after repeated immunizations with acetylated keyhole limpet hemocyanin (KLH).

    Isotype

    IgG1
  • Application Notes

    ELISA_Dilution: User Optimized

    Immunohistochemistry_Dilution: 1:200 - 1:1,000

    Western_Blot_Dilution: 1:500 - 1:2,000

    Other: User Optimized

    Comment

    This Protein G purified antibody has been tested for use in ELISA, immunohistochemistry and western blotting.  Specific conditions for reactivity should be optimized by the end user.  Approximately 1 μg of antibody is sufficient to detect 20 μg of acetylated chicken erythrocyte histones (sodium butyrate treated) by Western blotting using HRP Gt-a-Mouse IgG (p/n 610-103-121) and chemiluminescent substrate (p/n PICOMAX-110). Antibody provided in PBS pH 7.4.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Buffer: See application note.

    Stabilizer: 50 % (v/v) Glycerol

    Preservative: 0.09 % (w/v) Sodium Azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.

    Expiry Date

    12 months
  • Target

    Acetylated Lysine

    Alternative Name

    Lysine Acetylated

    Target Type

    Chemical

    Background

    Synonyms: acetyl Lysine antibody, Acetylated lysine antibody, Lysine antibody

    Background: Post-translational modifications of proteins play critical roles in the regulation and function of many known biological processes. A common posttranscriptional modification of lysine residues involves acetylation (1). The conserved amino-terminal domains of the four core histones (H2A, H2B, H3 and H4) contain lysines that are acetylated by histone acetyltransferases (HATs) and deacetylated by histone deacetylases (HDACs) (2). Protein posttranslational reversible lysine Nε-acetylation and deacetylation have been recognized as an emerging intracellular signaling mechanism that plays critical roles in regulating gene transcription, cell-cycle progression, apoptosis, DNA repair, and cytoskeletal organization (3). The regulation of protein acetylation status is impaired in the pathologies of cancer and polyglutamine diseases (4). HDACs therefore are promising targets for anticancer drugs currently in development (5).

You are here:
Chat with us!